The established antidepressant sertraline does not improve symptoms, wellbeing or survival in patients with advanced cancer who do not have major depression. The findings are reported early Online – timed to coincide with presentation of the paper at the American Society of Clinical Oncology meeting in Chicago – and in the July edition of The Lancet Oncology. [click link for full article]
Popularity: unranked [?]
